KAREN STONE: Open Payments
NPI 1740376557 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$862 in 43 payments from 11 companies in 2025. Trend: 2023 $2,540 · 2024 $1,998 · 2025 $862
Food & beverage: $862
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $348 |
| Gilead Sciences, Inc. | 2 | $149 |
| Janssen Biotech, Inc. | 4 | $80 |
| Aimmune Therapeutics, Inc. | 3 | $65 |
| Phathom Pharmaceuticals, Inc. | 6 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Ardelyx, Inc. | 2 | $40 |
| Madrigal Pharmaceuticals | 1 | $23 |
| Intercept Pharmaceuticals, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $21 |
Products named: SKYRIZI, Livdelzi, TREMFYA, LINZESS, ZENPEP, RINVOQ, VOQUEZNA, ENTYVIO.
Industry payments across FL — which companies pay providers there.
